Journal of the Korean Association of Oral and Maxillofacial Surgeons

  • 제33권3호
  • /
  • Pages.247-255
  • /
  • 2007
  • /
  • 2234-7550(pISSN)
  • /
  • 2234-5930(eISSN)
대한구강악안면외과학회 (The Korean Association of Oral and Maxillofacial Surgeons)
권호 표지

다형성선종에서 연골유래형성단백의 발현

EXPRESSION OF CARTILAGE DERIVED MORPHOGENIC PROTEIN IN PLEOMORPHIC ADENOMA

  • 이황재 (단국대학교 치과대학 구강악안면외과학교실) ;
  • 김철환 (단국대학교 치과대학 구강악안면외과학교실) ;
  • 김경욱 (단국대학교 치과대학 구강악안면외과학교실)
  • Lee, Hwang-Jae (Department of Oral & Maxillofacial surgery, College of Dentistry, Dankook University) ;
  • Kim, Chul-Hwan (Department of Oral & Maxillofacial surgery, College of Dentistry, Dankook University) ;
  • Kim, Kyung-Wook (Department of Oral & Maxillofacial surgery, College of Dentistry, Dankook University)
  • 발행 : 2007.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The bone morphogenic protein(BMP) can promote migration and growth of mesenchymal cells and initiate process for bone and cartilage formation. Cartilage-derived morphogenic protein(CDMP)-1 and -2 belong to the bone morphogenetic protein family in the transforming growth factor(TGF)-${\beta}$ superfamily. Although pleomorphic adenoma of the salivary glands is an epithelial tumor, it frequently shows ectopic cartilaginous formation with biomolecular studies. The mechanism of pathogenesis in cartilaginous formation is still controversy. We examined the expression and localization of CDMP-1 and -2, in comparison with the localization of cartilaginous matrix proteins, in human normal salivary glands and 20 cases of pleomorphic adenoma using immunohistochemical methods. The results were followed. 1. CMP-1 was immunolocalized in the striated ducts and the intercalated ducts, but not expressed in excretory duct, CDMP-2 was not expressed in the normal salivary glands. 2. CMP-1 was immunolocalized in the ductal cell and cuboidal neoplastic myoepithelial cells around the chondroid areas of the pleomorphic adenomas, whereas these molecules were not localized in the spindle-shaped neoplastic myoepithelial cells of the myxoid element in these tumors. CDMP-2 was expressed neither in normal salivary glands nor in any elements of the pleomorphic adenomas. 3. In transmission electron microscopic view, the tumor cells are composed of modifed myoepithelial cells between hyaline and myxoid stroma. 4. In Immuno-blot analysis, strong overexpression of CDMP-1 was frequently seen in pleomorphic adenomas, but the level of CDMP-2 was expressed minimally in pleomorphic adenoma. From the these results, it should be suggested that undifferentiated neoplastic myoepithelial cells around the chondroid areas expressed CDMP-1 and suggested that this molecule may play a role in the differentiation of neoplastic myoepithelial cells in pleomorphic adenoma, but not CDMP-2.

키워드

참고문헌

  1. Izumi T, Scully SP, Heydemann A, Bolander ME: Transforming growth factor beta 1 stimulates type II collagen expression in cultured periosteum derived cells. J Bone Miner Res 1992;7:115-121 https://doi.org/10.1002/jbmr.5650070116
  2. Iwasaki M, Nakata K, Nakahara H, Nakase T, Kimura T, Kimata K, Caplan AI Ono K: Transforming growth factor-beta 1 stimulates chondrogenesis and inhibits osteogenesis in high density culture of periosteum-derived cells. Endocrinology 1993;132:1603-1608 https://doi.org/10.1210/en.132.4.1603
  3. Nakase T, Nakahara H, Iwasaki M, Kimura T, Kimata K, Watanabe K, Caplan AI, Ono K: Clonal analysis for developmental potential of chick periosteum-derived cells: agar gel culture system. Biochem Biophys Res Commun 1993;195:1422-1428 https://doi.org/10.1006/bbrc.1993.2202
  4. Sampath TK, Muthukumaran N, Reddi AH: Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc Natl Acad Sci USA 1987;84:7109-7113
  5. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA: Novel regulators of bone formation: molecular clones and activities. Science 1988;242:1528-1534 https://doi.org/10.1126/science.3201241
  6. Reddi AH: Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 1998;16:247-252 https://doi.org/10.1038/nbt0398-247
  7. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee SJ: Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 1994;368:639-643 https://doi.org/10.1038/368639a0
  8. Chang SC, Hoang B, Thomas JT, Vukicevic S, Luyten FP, Ryba NJ, Kozak CA, Reddi AH, Moos Jr M: Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 1994;269:28227-28234
  9. Thomas JT, Kilpatrick MW, Lin K, Erlacher L, Lembessis P, Costa T, Tsipouras P, Luyten FP: Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 1997;17:58-64 https://doi.org/10.1038/ng0997-58
  10. Thomas JT, Lin K, Nandedkar M, Camargo M, Cervenka J, Luyten FP: A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nat Genet 1996;12:315-317 https://doi.org/10.1038/ng0396-315
  11. Polinkovsky A, Robin NH, Thomas JT, Irons M, Lynn A, Goodman FR, Reardon W, Kant SG, Brunner HG, van der Burgt I, Chitayat D, McGaughran J, Donnai D, Luyten FP, Warman ML: Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat Genet 1997;17:18-19 https://doi.org/10.1038/ng0997-18
  12. Gruber R, Mayer C, Schulz W, Graninger W, Peterlik M, Watzek G, Luyten FP, Erlacher L: Stimulatory effects of cartilage-derived morphogenetic proteins-1 and -2 on osteogenic differentiation of bone marrow stromal cells. Cytokine 2000;12:1630-1638 https://doi.org/10.1006/cyto.2000.0760
  13. Erlacher L, Ng CK, Ullrich R, Krieger S, Luyten FP: Presence of cartilage derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro. Arthritis Rheum 1998;41:263-273 https://doi.org/10.1002/1529-0131(199802)41:2<263::AID-ART10>3.0.CO;2-5
  14. Felix A, Rosa JC: Pleomorphic adenoma and carcinoma ex pleomorphicadenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy. Histopathology 2004;45(2):187-92 https://doi.org/10.1111/j.1365-2559.2004.01924.x
  15. Dardick I, Van Nostrand AWP, Jeans MTD, Rippstein P, Edwards V: Pleomorphic adenoma. II. Ultrastructural organization of 'stromal regions'. Hum Pathol 1983;14:798-809 https://doi.org/10.1016/S0046-8177(83)80302-5
  16. Erlandson RA, Cardon-Cardo C, Higgins PJ: Histogenesis of benign pleomorphic adenoma (mixed tumor) of the major salivary glands. An ultrastructural and immunohistochemical study. Am J Surg Pathol 1984;8:803-820 https://doi.org/10.1097/00000478-198411000-00001
  17. Morinaga S, Nakajima T, Shimosato Y: Normal and neoplastic myoepithelial cells in salivary glands: an immunohistochemical study. Hum Pathol 1987;18:1218-1226 https://doi.org/10.1016/S0046-8177(87)80404-5
  18. Hatakeyama S, Satoh M, Yoshimura N, Otsu T: Immunohistochemical localization of bone morphogenetic proteins(BMPs) in salivary gland pleomorphic adenoma. J Oral Pathol Med 1994;23:232-236 https://doi.org/10.1111/j.1600-0714.1994.tb01119.x
  19. Spiro RH: Salivary neoplasms: overview of a 35-year experience with 807 patients. Head Neck Surg 1986;8:177-184 https://doi.org/10.1002/hed.2890080309
  20. Seifert G, Langrock I, Donath K: A pathological classification of pleomorphic adenoma of the salivary glands. HNO 1976;24:415-426
  21. Naeim F, Frosberg MI, Waisman J, et al: Mixed tumors of the salivary glands: growth pattern and Recurrence. Arch Pathol Lab Med 1976;100:271-275
  22. Takeuchi J, Sobue M, Yoshida M, et al: Pleomorphic adenoma of the salivary gland. Cancer 1975;36:1771-1789 https://doi.org/10.1002/1097-0142(197511)36:5<1771::AID-CNCR2820360532>3.0.CO;2-Z
  23. Mylius EA: The identification and the role of the myoepithelial cell in salivary gland tumors. Acta Pathol Microbiol Scand (Suppl 139) 1960;50:1-81 https://doi.org/10.1111/j.1699-0463.1960.tb01166.x
  24. Fernando MM, Christian M: Histology of the major salivary glands Am J Surg Pathol 1989;13:879-899 https://doi.org/10.1097/00000478-198910000-00008
  25. Hubner G, Klein HJ, Kleinsasser O, et al: Role of myoepithelial cells in the development of salivary gland tumors. Cancer 1971;27:1255-1261 https://doi.org/10.1002/1097-0142(197105)27:5<1255::AID-CNCR2820270533>3.0.CO;2-1
  26. Harriette J. Kahn, Reuben B, Alexander M, et al: Myoepithelial cells in salivary gland tumors. Arch Pathol Lab Med 1985;109:190-195
  27. Welsh RA, Meyer AT: Mixed tumors of human salivary gland. Histogenesis Arch Pathol 1968;85:433-447
  28. Giuliano quitntarelli Leonard Robinson. The glycosaminoglycans of salivary gland tumors. 1967;51:19-37
  29. Batsakis JG: Salivary gland neoplasia. An outcome of modified morphogenesis and cytodifferentiation. Oral Surg 1980;49:229-232 https://doi.org/10.1016/0030-4220(80)90053-5
  30. Eversole LR: Histogenic classification of salivary tumors. Arch Pathol 1971;92:433-443
  31. Doyle LE, JA Lynn, IT Panapiio, et al: Ultrastructure of the chondroid regions of benign mixed tumor of salivary gland. Cancer 1968;22:225-233 https://doi.org/10.1002/1097-0142(196807)22:1<225::AID-CNCR2820220126>3.0.CO;2-X
  32. Shirasuna K, Sato M, Miyazaki T: A myoepithelial cell line estabolished from a human pleomorphic adenoma arising in minor salivary gland. Cancer 1980;45:287-305
  33. Seifert G, Sobin LH: World Health Organization international histologic classification of tumors. Histologic typing of salivary gland tumors. Springer, Berlin Heidelberg New York, 1991
  34. Ara?jo VC, Ara?jo NS: Vimentin as a marker of myoepithelial cells in salivary gland tumors. Eur Arch Otorhinolayngol 1990;247:252-255 https://doi.org/10.1007/BF00178997
  35. Araujo VC, Carvalho YR, Araujo NS: Actin versus vimentin in myoepithelial cells of salivary gland tumors. A comparative study. Oral Surg 1994;77:387-391 https://doi.org/10.1016/0030-4220(94)90201-1
  36. Bataski JG, Kraemer B, Sciubba JJ: The pathology of head and neck tumors. The myoepithelial cells and its participation in salivary gland neoplasia. Head Neck Surg 1983;5:222-233 https://doi.org/10.1002/hed.2890050307
  37. Dardick I, Van Nostrand P: Myoepithelial cells in salivary gland tumors-revisited. Head Neck Surg 1985;7:395-408 https://doi.org/10.1002/hed.2890070509
  38. Dardick I, Van Nostrand P, Jeans D, et al: Pleomorphic adenoma. I. Ultrastructural organization of 'epithelial' regions. Hum Patho 1983;14:780-797 https://doi.org/10.1016/S0046-8177(83)80301-3
  39. Dardick I, Van Nostrand P, Jeans D, et al: Pleomorphic adenoma. II. Ultrastructural organization of 'stromal' regions. Hum Pathol 1983;14:798-809 https://doi.org/10.1016/S0046-8177(83)80302-5
  40. Kahn HJ, Baumal R, Marks A, et al: Myoepithelial cells in salivary gland tumors. An immunohistochemical study. Arch Pathol Lab Med 1985;109:190-195
  41. Morinage S, Nakajima T, Shimosato Y: Normal and neoplastic myoepithelial cells in salivary glands. Hum Pathol 1987;18:1218- 1226 https://doi.org/10.1016/S0046-8177(87)80404-5
  42. Kibbey MC, Royce LS, Dym M, et al: Glandular-like morphogenesis of human submandibular tumor cell line A253 on basement membrane components. Exp Cell Res 1992;198:343-351 https://doi.org/10.1016/0014-4827(92)90389-P
  43. Li ML, Aggeler J, Farson DA, et al: Influence of a resonstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc Natl Acad Sci USA 1987;84:136-140
  44. Caselitz J: Basement membrane antigens as tumor markers. Curr Top Pathol 1987;77:223-243
  45. Cheng J, Saku T, Okabe H, et al: Basement membrane protein adenoid cystic carcinoma. Cancer 1992;69:2631-2640 https://doi.org/10.1002/1097-0142(19920601)69:11<2631::AID-CNCR2820691103>3.0.CO;2-P
  46. Lam RMY: An electron microscopic histochemical study of the histogenesis of major salivary gland pleomorphic adenoma. Ultrastruct Pathol 1985;8:207-223 https://doi.org/10.3109/01913128509142154
  47. Saku T, Cheng J, Okabe H, et al: Immunolocalization of basement membrane proteins in the stroma of salivary gland pleomorphic adenoma. J Oral Pathol Med 1990;19:208-214 https://doi.org/10.1111/j.1600-0714.1990.tb00827.x
  48. Skalova A, Leibo I: Basement membrane proteins in salivary gland tumors. Virchows Arch 1992;420:425-431 https://doi.org/10.1007/BF01600514
  49. Luyten FP: Cartilage-derived morphogenetic protein-1. Int J Biochem Cell Biol 1997;29:1241-1244 https://doi.org/10.1016/S1357-2725(97)00025-3
  50. Hotten GC, Matsumoto T, Kimura M, Bechtold RF, Kron R, Ohara T, Tanaka H, Satoh Y, Okazaki M, Shirai T, Pan H, Kawai S, Pohl JS, Kudo A: Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development. Growth Factors 1996;13:65-74 https://doi.org/10.3109/08977199609034567
  51. Lyons KM, Pelton RW, Hogan BLM: Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-b-like genes coordinately regulate aspects of embryonic development. Genes Dev 1989;3:1657-1668 https://doi.org/10.1101/gad.3.11.1657
  52. Lyons KM, Pelton RW, Hogan BL: Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development 1990; 109:833-844
  53. Waldron CA: Mixed tumor (pleomorphic adenoma) and myoepithelioma. In: Ellis GL, Auclair PL, Gnepp DR (eds) Surgical pathology of the salivary glands. Saunders, hiladelphia, pp165-182, 1991
  54. Cheah KSE, Lau ET, Au PKC, Tam PPL: Expression of the mouse a1(II) collagen gene is not restricted to cartilage during development. Development 1991;111:945-953
  55. Wood A, Ashhurst PE, Corbett A, Thorogood P: The transient expression of type II collagen at tissue interfaces during mammalian craniofacial development. development 1991;111:955-968
  56. Kusafuka K, Yamaguchi A, Kayano T, Fujuwara M, Takemura T:Expression of bone morphogenetic proteins in salivary pleomorphic adenomas. Virchows Arch 1998;432:247-253 https://doi.org/10.1007/s004280050162
  57. Kusafuka K, Yamaguchi A, Kayano T, Takemura T: Immunohistochemical localization of bone morphogenetic protein-6 in salivary pleomorphic adenomas. Pathol Int 1999;49:1023-1027 https://doi.org/10.1046/j.1440-1827.1999.00991.x
  58. Kusafuka K, Yamaguchi A, Kayano T, Takemura T: Immunohistochemical localization of fibroblast growth factors (FGFs) and FGF receptor-1 in human normal salivary glands and pleomorphic adenomas. J Oral Pathol Med 1998;27:287-292 https://doi.org/10.1111/j.1600-0714.1998.tb01958.x